Underwriter Agreements. The Company is not a party to any agreement with an agent or underwriter for any other “at-the-market” or continuous equity transaction, other than that certain Purchase Agreement, dated as of May 2, 2018, between the Company and Lincoln Park Capital Fund, LLP and any related agreements between the Company and Lincoln Park Capital Fund, LLP.
Appears in 1 contract
Underwriter Agreements. The Company is not a party to any agreement with an agent or underwriter for any other “at-the-market” or continuous equity transaction, transaction other than (i) that certain Purchase AgreementAgreement , dated as of May 2September 26, 20182019, between the Company and Lincoln Park Capital Fund, LLP LLC (the “Lincoln Park Agreement”) and any related agreements (ii) that certain Sales Agreement, dated December 4, 2020, between the Company and Lincoln Park Capital Fund, LLPA.G.P./ Alliance Global Partners (the “AGP Agreement). .
Appears in 1 contract
Samples: Common Stock at Market Issuance Sales Agreement (Isun, Inc.)
Underwriter Agreements. The Company is not a party to any agreement with an agent or underwriter for any other “at-the-market” or continuous equity transaction, transaction other than that certain Purchase AgreementAgreement , dated as of May 2September 26, 20182019, between the Company and Lincoln Park Capital Fund, LLP and any related agreements between LLC (the Company and “Lincoln Park Capital Fund, LLPAgreement”).
Appears in 1 contract
Underwriter Agreements. The Except for the Purchase Agreement between the Company and Lincoln Park Capital Fund, LLC, dated October 8, 2015, the Company is not a party to any agreement with an agent or underwriter for any other “at-the-at the market” or continuous equity transaction, other than that certain Purchase Agreement, dated as of May 2, 2018, between the Company and Lincoln Park Capital Fund, LLP and any related agreements between the Company and Lincoln Park Capital Fund, LLP.
Appears in 1 contract
Samples: At Market Issuance Sales Agreement (Onconova Therapeutics, Inc.)